Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Taysha Gene Therapies
Biotech
Taysha links gene therapy to motor gains in small Rett study
The principal investigator tracked improvements in motor skills, communication and other measures in adults with 25 to 52 weeks of follow up.
Nick Paul Taylor
Jun 18, 2024 11:44am
Taysha ends work on gene therapy as Astellas walks away
Sep 20, 2023 4:40am
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
Astellas continues gene therapy push with $50M stake in Taysha
Oct 24, 2022 7:30pm
Layoff surge hits 3 more biotechs
Mar 31, 2022 6:48pm
